{
    "rcn": "209464",
    "acronym": "HARMONY",
    "topics": "IMI2-2015-06-04",
    "title": "Healthcare Alliance for Resourceful Medicines Offensive against Neoplasms in HematologY",
    "startDate": "01/01/2017",
    "endDate": "31/12/2021",
    "objective": "Despite significant recent progress in the field of hematological malignancies (HMs), with increasing survival rates and improvement in quality of life, many children and adults with HMs still die from these disorders or experience disabling complications. Therefore, improvement of health care of HMs is an unmet medical need. Thus, it is important to define and align standard and efficient sets of HMs outcomes to measure and evaluate HM data for clinical decisions, long term risk/benefit profile, reimbursement, value analysis, and clinical trials design. Improving outcome measures and endpoint definitions by taking into account 'real-life' data and differences in cross-national healthcare practice will undoubtedly result in an optimized, sustainable and effective treatment delivery, as well as in desirable and innovative accelerated pathways for novel drug availability. All these challenges will be addressed within a pan-EU perspective by HARMONY (Healthcare Alliance for Resourceful Medicines Offensive against Neoplasms in HematologY), a comprehensive public-private European consortium of excellence.\nHARMONY consortium is made up of 51 partners: 44 participants from 10 European countries and 7 pharmaceutical companies from the EFPIA. HARMONY aims to assemble, assess, connect, and analyze heterogeneous HM patient derived Big Data sets to define sets of outcome indicators that can be used for decision-making by key healthcare stakeholders. The consortium will orchestrate leading experts and working cooperative groups in HMs, European study alliances, pharmaceutical market leaders, patient advocacy groups, HTA and regulatory agencies, to: (i) optimize Europe-wide data collection and create a high-quality HM data repository for further explorative studies; (ii) establish a clinical data-sharing platform that empowers clinicians, patients and policy stakeholders to improve decision-making procedures and identify appropriate treatments to patients with HMs (iii) foster the design of innovative clinical and pre-clinical studies; (iv) define meaningful and harmonized clinical endpoints and outcomes in HMs in order to facilitate clinical decision-making; (v) identify specific biomarkers, which better define outcome parameters (vi) provide novel resources and algorithms to more rapidly advance innovative concepts of patient management in HMs; (vii) involve the patient perspective; (viii) provide a framework for legal, ethical and governance issues. Moreover, the consortium will integrate molecular markers to improve patient outcomes and personalized health management processes.\nRegarding governance, HARMONY has a multi-level organizational structure, which includes representatives from all stakeholders, and which ensures efficient and effective management, decision-making, and control of work package (WP) activities. This will be accomplished by creating well-defined management and decision-making structures with clear accountabilities and decision rules. The Consortium Management Bodies will be the Executive Committee, the Steering Committee, and the General Assembly. The management of Big Data is one of the key-features in the consortium. Therefore a Data Quality Supervision Committee will define the quality criteria for 'valid records' and perform the review of the quality of the patientsí data provided by different sources (beneficiaries, Associated Members and Co-operative Working Groups).\nHARMONY is covering seven HMs (multiple myeloma, acute myeloid leukemia, acute lymphoblastic leukemia, chronic lymphocytic leukemia, non-Hodgkinís lymphoma, myelodysplastic syndromes and pediatric HMs) structured in eight WPs, including: i) the most important key opinion leaders in each disease; ii) several European institutions involved in the study of HMs; iii) the EFPIA lead companies in HMs; iv) institutions experienced in studying 'omics' data; v) a large panel of stakeholders (regulatory agencies, HTA, and patients organiza",
    "totalCost": "39745617",
    "ecMaxContribution": "20200000",
    "coordinator": "FUNDACION INSTITUTO DE ESTUDIOS DE CIENCIAS DE LA SALUD DE CASTILLA Y LEON",
    "coordinatorCountry": "ES",
    "participants": "MEDIZINISCHE UNIVERSITAET WIEN;UNIVERSITA DEGLI STUDI DI ROMA TORVERGATA;HEINRICH-HEINE-UNIVERSITAET DUESSELDORF;FUNDACIO PRIVADA INSTITUT D'INVESTIGACIO ONCOLOGICA DE VALL-HEBRON;German Society Pediatric Oncology Hematology GmbH gemeinn¸tzig;GMV SOLUCIONES GLOBALES INTERNET SAU;LUDWIG-MAXIMILIANS-UNIVERSITAET MUENCHEN;HELSINGIN YLIOPISTO;THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE;European Research Initiative on CLL e.v.;European Society for Blood and Marrow Transplantation;Masarykova univerzita;Agencia EspaÒola de Medicamentos y Productos Sanitarios;MediSapiens Oy;Genome Research Limited;UNIVERSITAET ULM;EUROPEAN ORGANISATION FOR RESEARCH AND TREATMENT OF CANCER AISBL;NOVARTIS PHARMA AG;ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS;Group for Research on Adult Acute Lymphoblastic Leukemia;UNIVERSITY OF NEWCASTLE UPON TYNE;Amgen NV;UNIVERSITA DEGLI STUDI DI TORINO;Celgene International II Sarl;FUNDACION PARA LA INVESTIGACION DEL HOSPITAL UNIVERSITARIO LA FE DE LA COMUNIDAD VALENCIANA;Takeda Development Centre Europe Ltd.;European Hematology Association;NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE;UNIVERSITY OF YORK;European Alliance for Personalised Medicine;Barts and the London NHS Trust;UNIVERSIDAD DE NAVARRA;STICHTING VUMC;Bayer Pharma AG;ELN Foundation;JOHANN WOLFGANG GOETHE-UNIVERSITATFRANKFURT AM MAIN;VIB;Menarini Ricerche S.p.A.;LeukaNET e.V.;ALMA MATER STUDIORUM - UNIVERSITA DI BOLOGNA;Groupe Francophone des MyÈlodysplasies;The Lymphoma Study Association;BUNDESINSTITUT FUR ARZNEIMITTEL UND MEDIZINPRODUKTE;ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM;Fondazione Italiana per lo studio delle sindromi mielodisplastiche onlus;Synapse Research Management Partners S.L;OSPEDALE PEDIATRICO BAMBINO GESU;MLL Munich Leukemia Laboratory GmbH;FundaciÛ Institut de Recerca Contra la Leucemia Josep Carreras;JANSSEN PHARMACEUTICA NV",
    "participantCountries": "AT;IT;DE;ES;FI;UK;NL;CZ;BE;CH;FR",
    "projectParticipants": {
        "995991539": {
            "orgId": "995991539",
            "orgName": "FUNDACION PARA LA INVESTIGACION DEL HOSPITAL UNIVERSITARIO LA FE DE LA COMUNIDAD VALENCIANA",
            "ecContrib": 1100062
        },
        "997512402": {
            "orgId": "997512402",
            "orgName": "GMV SOLUCIONES GLOBALES INTERNET SAU",
            "ecContrib": 1203548
        },
        "999563952": {
            "orgId": "999563952",
            "orgName": "Agencia Española de Medicamentos y Productos Sanitarios",
            "ecContrib": 199998
        },
        "999524861": {
            "orgId": "999524861",
            "orgName": "EUROPEAN ORGANISATION FOR RESEARCH AND TREATMENT OF CANCER AISBL",
            "ecContrib": 100000
        },
        "999856116": {
            "orgId": "999856116",
            "orgName": "HEINRICH-HEINE-UNIVERSITAET DUESSELDORF",
            "ecContrib": 150000
        },
        "999993953": {
            "orgId": "999993953",
            "orgName": "ALMA MATER STUDIORUM - UNIVERSITA DI BOLOGNA",
            "ecContrib": 795153
        },
        "999981343": {
            "orgId": "999981343",
            "orgName": "GENOME RESEARCH LIMITED",
            "ecContrib": 0
        },
        "919322739": {
            "orgId": "919322739",
            "orgName": "STICHTING VUMC",
            "ecContrib": 150000
        },
        "999988424": {
            "orgId": "999988424",
            "orgName": "ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM",
            "ecContrib": 146833
        },
        "999844864": {
            "orgId": "999844864",
            "orgName": "UNIVERSITA DEGLI STUDI DI ROMA TORVERGATA",
            "ecContrib": 152770
        },
        "945511478": {
            "orgId": "945511478",
            "orgName": "Menarini Ricerche S.p.A.",
            "ecContrib": 0
        },
        "916002526": {
            "orgId": "916002526",
            "orgName": "The Lymphoma Study Association",
            "ecContrib": 163100
        },
        "987932003": {
            "orgId": "987932003",
            "orgName": "European Society for Blood and Marrow Transplantation",
            "ecContrib": 100100
        },
        "952792395": {
            "orgId": "952792395",
            "orgName": "MediSapiens Oy",
            "ecContrib": 149250
        },
        "997517058": {
            "orgId": "997517058",
            "orgName": "Amgen NV",
            "ecContrib": 0
        },
        "936119647": {
            "orgId": "936119647",
            "orgName": "UNIVERSITAET ULM",
            "ecContrib": 400000
        },
        "999641746": {
            "orgId": "999641746",
            "orgName": "UNIVERSIDAD DE NAVARRA",
            "ecContrib": 149500
        },
        "999861936": {
            "orgId": "999861936",
            "orgName": "UNIVERSITA DEGLI STUDI DI TORINO",
            "ecContrib": 149613
        },
        "999977172": {
            "orgId": "999977172",
            "orgName": "THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE",
            "ecContrib": 0
        },
        "940777781": {
            "orgId": "940777781",
            "orgName": "European Alliance for Personalised Medicine",
            "ecContrib": 125000
        },
        "951404713": {
            "orgId": "951404713",
            "orgName": "FUNDACION INSTITUTO DE ESTUDIOS DE CIENCIAS DE LA SALUD DE CASTILLA Y LEON",
            "ecContrib": 8569353
        },
        "999978433": {
            "orgId": "999978433",
            "orgName": "LUDWIG-MAXIMILIANS-UNIVERSITAET MUENCHEN",
            "ecContrib": 158915
        },
        "974284491": {
            "orgId": "974284491",
            "orgName": "LeukaNET e.V.",
            "ecContrib": 500000
        },
        "999651931": {
            "orgId": "999651931",
            "orgName": "VIB",
            "ecContrib": 149933
        },
        "935297572": {
            "orgId": "935297572",
            "orgName": "European Hematology Association",
            "ecContrib": 831750
        },
        "984454262": {
            "orgId": "984454262",
            "orgName": "NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE",
            "ecContrib": 400000
        },
        "998293931": {
            "orgId": "998293931",
            "orgName": "BUNDESINSTITUT FUR ARZNEIMITTEL UND MEDIZINPRODUKTE",
            "ecContrib": 200000
        },
        "999978336": {
            "orgId": "999978336",
            "orgName": "UNIVERSITY OF YORK",
            "ecContrib": 299926
        },
        "923028430": {
            "orgId": "923028430",
            "orgName": "Group for Research on Adult Acute Lymphoblastic Leukemia",
            "ecContrib": 150000
        },
        "998837810": {
            "orgId": "998837810",
            "orgName": "OSPEDALE PEDIATRICO BAMBINO GESU",
            "ecContrib": 149976
        },
        "999989976": {
            "orgId": "999989976",
            "orgName": "MEDIZINISCHE UNIVERSITAET WIEN",
            "ecContrib": 400000
        },
        "999880657": {
            "orgId": "999880657",
            "orgName": "Masarykova univerzita",
            "ecContrib": 100000
        },
        "999994535": {
            "orgId": "999994535",
            "orgName": "HELSINGIN YLIOPISTO",
            "ecContrib": 150000
        },
        "999645432": {
            "orgId": "999645432",
            "orgName": "ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS",
            "ecContrib": 150000
        },
        "923788910": {
            "orgId": "923788910",
            "orgName": "Fondazione Italiana per lo studio delle sindromi mielodisplastiche onlus",
            "ecContrib": 150000
        },
        "998135433": {
            "orgId": "998135433",
            "orgName": "Barts and the London NHS Trust",
            "ecContrib": 152750
        },
        "995163935": {
            "orgId": "995163935",
            "orgName": "FUNDACIO PRIVADA INSTITUT D'INVESTIGACIO ONCOLOGICA DE VALL-HEBRON",
            "ecContrib": 150000
        },
        "999985417": {
            "orgId": "999985417",
            "orgName": "UNIVERSITY OF NEWCASTLE UPON TYNE",
            "ecContrib": 150000
        },
        "986212290": {
            "orgId": "986212290",
            "orgName": "MLL Munich Leukemia Laboratory GmbH",
            "ecContrib": 199766
        },
        "999978724": {
            "orgId": "999978724",
            "orgName": "JOHANN WOLFGANG GOETHE-UNIVERSITATFRANKFURT AM MAIN",
            "ecContrib": 150000
        },
        "923133869": {
            "orgId": "923133869",
            "orgName": "German Society Pediatric Oncology Hematology GmbH gemeinnützig",
            "ecContrib": 151475
        },
        "951078308": {
            "orgId": "951078308",
            "orgName": "Fundació Institut de Recerca Contra la Leucemia Josep Carreras",
            "ecContrib": 153348
        },
        "930535939": {
            "orgId": "930535939",
            "orgName": "European Research Initiative on CLL e.v.",
            "ecContrib": 147748
        }
    },
    "calculatedTotalContribution": 18849867
}